Farms.com Home   News

Prairies Dealing With Extremely Dry Conditions

Farmers that have been seeing some snow this week probably won't mind pushing seeding back in order to benefit from the moisture.
 
The majority of the prairies are being impacted by dry to extremely dry conditions, that not only impact the prairies, but carry on through the Western half of the U-S and Mexico as well.
 
Drew Lerner, the Senior Agri-Meteorologist with World Weather Inc, says the system which brought the snow this week mainly impacted parts of Manitoba and Saskatchewan.
 
"Moisture totals at least in a part of that region will temporarily be lifting the moisture profile at least in the topsoil, but it's not all the way across the prairies. There's a lot of other areas that will not be impacted by this."
 
Lerner notes in studying past data, even within the last couple of years, they've found there's a tendency for drought relief in the southern part of the prairies to occur in April and May.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.